Food ingredient solutions provider Ingredion (NYSE: INGR) met Wall Street’s revenue expectations in Q3 2026, but sales fell by 1.3% year on year to $1.79 billion. Its non-GAAP profit of $2.28 per share was 12.2% below analysts’ consensus estimates.

Is now the time to buy INGR? Find out in our full research report (it’s free for active Edge members).

StockStory’s take

Ingredion’s results for the latest quarter met Wall Street’s revenue expectations, but adjusted profit fell short amid ongoing cost and demand challenges. Management attributed the earnings shortfall primarily to higher manufacturing expenses at the Argo facility, elevated input costs—especially for tapioca starch—and continued softness in U.S. and Canadian food and beverage markets. CEO Jim Zallie described the consumer environment as “weaker than anticipated,” emphasizing that demand for sweeteners and starches declined as customers adjusted to higher prices and shifted to smaller package sizes.

Looking ahead, management lowered full-year profit guidance, reflecting continued caution on consumer demand and the lingering impact of operational issues at Argo. Zallie indicated that recovery in manufacturing yields and normalization of maintenance spending are priorities, but warned that pricing pressures and input cost volatility could persist. CFO Diego Reynoso highlighted the company’s intent to offset inflation through targeted pricing and productivity initiatives, but cautioned, “We are being more cautious with our forecast given the ongoing volatility in energy and raw material costs.”

Key insights from management’s remarks

Ingredion’s management identified operational setbacks at Argo, raw material cost inflation, and uneven regional demand as the main contributors to margin compression and weaker profitability this quarter.

• Argo facility challenges: Ongoing operational inefficiencies at the Argo plant led to lower production yields and elevated maintenance expenses, delaying expected financial recovery despite stabilized production and rebuilt inventories.
• Tapioca cost surge: Record-high tapioca prices, driven by adverse weather and supply shortages in Thailand, significantly increased costs in the Texture & Healthful Solutions segment. Management noted a quarter-lag in recouping these expenses through customer pricing.
• LATAM operational resilience: While Latin America volumes benefited from new brewing contracts and facility consolidation in Brazil, profitability was impacted by the Colombian earthquake, which disrupted customer deliveries, and a strong Mexican peso, which created currency headwinds.
• Shifting consumer behavior: U.S. and Canadian consumers responded to higher prices by reducing unit purchases or switching to smaller packages, particularly in sweeteners and packaged foods, dampening volumes for Ingredion’s core products.
• Acquisition integration underway: The planned Tate & Lyle acquisition is progressing through regulatory review, with integration planning focused on expanding ingredient solutions and capturing synergies once closed in 2027.

Drivers of future performance

Ingredion’s outlook is shaped by a focus on restoring operational efficiency, managing input cost volatility, and expanding higher-margin product lines while navigating subdued consumer demand.

• Argo recovery and cost control: Management is prioritizing improvements in Argo’s production yields and tighter maintenance spending to restore profitability, though recovery is expected to be gradual and dependent on stabilizing consumer demand in North America.
• Input cost and pricing management: The company expects ongoing volatility in raw materials—especially tapioca and energy—to impact margins. Management aims to offset these pressures through contractual price pass-throughs, but recognizes a lag in recovery and potential for further headwinds.
• Growth in solutions-oriented segments: Ingredion is investing in Clean Label and Texture & Healthful Solutions, leveraging reformulation trends among food manufacturers. Management expects continued pipeline expansion, supported by customer demand for healthier, affordable options and enhanced by the forthcoming integration with Tate & Lyle.

Catalysts in upcoming quarters

In the quarters ahead, the StockStory team will watch (1) progress on operational efficiency and cost containment at Argo, (2) stabilization or improvement in U.S. and Canadian consumer demand for food ingredients, and (3) successful integration planning for the Tate & Lyle acquisition. Monitoring input cost trends and the pace of recovery in higher-margin product segments will also be critical for tracking Ingredion’s path to improved profitability.

Ingredion currently trades at $98.55, up from $97.46 just before the earnings. Is the company at an inflection point that warrants a buy or sell? The answer lies in our full research report (it’s free).

Now could be the perfect time to invest in these stocks

ALSO WORTH WATCHING: Top 5 Momentum Stocks. The best time to own a great stock is when the market is finally noticing it. These aren’t just high-quality businesses. Something is happening with them right now. Elite fundamentals meet near-term momentum — both boxes checked at the same time.

Find out which stocks our AI platform is flagging this week. See this week’s Strong Momentum stocks — FREE. Get Our Strong Momentum Stocks for Free HERE.

Stocks that have made our list include now familiar names such as Nvidia (+1,460% between June 2020 and June 2025) as well as under-the-radar businesses like the once-small-cap company Comfort Systems (+1,154% between June 2020 and June 2025). Find your next big winner with StockStory today.